Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions

Ventricular tachycardia (VT) caused by myocardial scaring bears a significant risk of mortality and morbidity. Antiarrhythmic drug therapy (AAD) and catheter ablation remain the cornerstone of VT management, but both treatments have limited efficacy and potential adverse effects. Stereotactic body r...

Full description

Bibliographic Details
Main Authors: Raphael Jumeau, Mahmut Ozsahin, Juerg Schwitter, Olgun Elicin, Tobias Reichlin, Laurent Roten, Nicolaus Andratschke, Michael Mayinger, Ardan M. Saguner, Jan Steffel, Oliver Blanck, Marie-Catherine Vozenin, Raphael Moeckli, Michele Zeverino, Véronique Vallet, Claudia Herrera-Siklody, Patrizio Pascale, Jean Bourhis, Etienne Pruvot
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
ventricular tachycardia
radiotherapy
stereotactic radiotherapy
ablation
noninvasive
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2020.00108/full

Internet

https://www.frontiersin.org/article/10.3389/fcvm.2020.00108/full

Similar Items